These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3067982)

  • 1. Metastasis of unknown origin.
    Haskell CM; Cochran AJ; Barsky SH; Steckel RJ
    Curr Probl Cancer; 1988; 12(1):5-58. PubMed ID: 3067982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis of unknown origin.
    Perchalski JE; Hall KL; Dewar MA
    Prim Care; 1992 Dec; 19(4):747-57. PubMed ID: 1465485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site.
    Hainsworth JD; Greco FA
    Semin Oncol; 1993 Jun; 20(3):279-86. PubMed ID: 8503024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of unknown primary tumors].
    Dodion P; De Valeriola D
    Bull Cancer; 1989; 76(9):939-46. PubMed ID: 2695183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic adenocarcinoma of unknown primary origin.
    Hammar SP
    Hum Pathol; 1998 Dec; 29(12):1393-402. PubMed ID: 9865824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of metastatic neoplasms with unknown primary.
    Bochtler T; Löffler H; Krämer A
    Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of postmortem examination in cases of metastasis of unknown origin-20-year retrospective data from a tertiary care center.
    Al-Brahim N; Ross C; Carter B; Chorneyko K
    Ann Diagn Pathol; 2005 Apr; 9(2):77-80. PubMed ID: 15806513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs).
    Pisacane A; Cascardi E; Berrino E; Polidori A; Sarotto I; Casorzo L; Panero M; Boccaccio C; Verginelli F; Benvenuti S; Dellino M; Comoglio P; Montemurro F; Geuna E; Marchiò C; Sapino A
    Virchows Arch; 2023 Mar; 482(3):463-475. PubMed ID: 36346458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity.
    Hainsworth JD; Johnson DH; Greco FA
    Ann Intern Med; 1988 Sep; 109(5):364-71. PubMed ID: 2841895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and therapeutic management of cancer of an unknown primary.
    Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
    Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.
    Hainsworth JD; Johnson DH; Greco FA
    J Clin Oncol; 1992 Jun; 10(6):912-22. PubMed ID: 1375284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of unknown primary (CUP).
    Pavlidis N; Fizazi K
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis of unknown origin: the role of fine-needle aspiration cytology.
    Reyes CV; Thompson KS; Jensen JD; Choudhury AM
    Diagn Cytopathol; 1998 May; 18(5):319-22. PubMed ID: 9582563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancies of undetermined primary origin.
    Bitran JD; Ultmann JE
    Dis Mon; 1992 Apr; 38(4):213-60. PubMed ID: 1547698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
    Srodon M; Westra WH
    Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic cancer with unknown primary.
    Greenberg BR; Lawrence HJ
    Med Clin North Am; 1988 Sep; 72(5):1055-65. PubMed ID: 2842554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing carcinomas of unknown primary site.
    Hainsworth JD; Greco FA
    Oncology (Williston Park); 1988 Jul; 2(7):43-9, 52-4. PubMed ID: 3275052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of patients with cancer of unknown primary site.
    Hainsworth JD; Greco FA
    Oncology (Williston Park); 2000 Apr; 14(4):563-74; discussion 574-6, 578-9. PubMed ID: 10826316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metastases of unknown origin--principles of diagnosis and treatment].
    Petrović D; Muzikravić L; Jovanović D
    Med Pregl; 2007; 60(1-2):29-36. PubMed ID: 17853708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.